Filana Therapeutics (SAVA) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.92
-0.68
-0.45
-0.21

Details

Expected EPS
-0.23
Actual EPS
-0.21
Surprise EPS
0.02
Surprise Percent
+8.7%

Description

⁨Filana Therapeutics⁩ (⁦SAVA⁩) has reported earnings of ⁦-0.21⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts